Le Moigne, R, et. al. EPI-7386 is a novel N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer. European Society of Medical Oncology (ESMO) 2019 Congress. (Abstract ID 503P).

Read More > European Society of Medical Oncology 2019 Congress Poster